The Neuroinflammasome in Alzheimer’s Disease and Cerebral Stroke

Aim/Background: This review investigated a patient with Alzheimer’s disease (AD) treated with 4,4’-diaminodiphenyl sulfone (DDS) as a neuroinflammasome competitor. Methods: We monitored AD’s progression through numeric clinical staging (NCS) with a new biomarker. NCS was determined by the presence o...

Full description

Bibliographic Details
Main Authors: Jong-hoon Lee, Chul Joong Lee, Jungwuk Park, So Jeong Lee, Su-hee Choi
Format: Article
Language:English
Published: Karger Publishers 2021-06-01
Series:Dementia and Geriatric Cognitive Disorders Extra
Subjects:
Online Access:https://www.karger.com/Article/FullText/516074